He did but I am not sure how starting a trial or signing a CLBP partnership deal would 'confuse' the FDA in any way .... these CLBP items have nothing to do with the BLA or in fact Remestemcel-L given Rexlemestrocel-L is a different treatment for starters .....
.... I would also add that anyone who thinks big pharma wouldn't attempt to capitalise on the back of any FDA setback (should it happen) are a little naïve
If CLBP is 'right to go" then get on with it I say .... and of course if a CLBP partnership outside of the Grunenthal licensed regions is also ready/sitting in the background then execute it and get things moving .... don't claim that some of the funds from the recent CR were intended to be used to get the ball rolling / initiation of patient enrolment when in almost 3 months we haven't enrolled anyone is all I am saying ? IMO the delay in starting the CLBP trial is due to Mesoblast wanting to finalise the CLBP partnership deal first ... of course more than happy to be wrong
GLTAH
2023 The Final Countdown, page-1378
-
- There are more pages in this discussion • 2,026 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |